Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

PURPOSE: The EML4-ALK fusion oncogene represents a novel molecular target in a small subset of non–small-cell lung cancers (NSCLC). To aid in identification and treatment of these patients, we examined the clinical characteristics and treatment outcomes of patients who had NSCLC with and without EML...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Shaw, Alice T., Yeap, Beow Y., Mino-Kenudson, Mari, Digumarthy, Subba R., Costa, Daniel B., Heist, Rebecca S., Solomon, Benjamin, Stubbs, Hannah, Admane, Sonal, McDermott, Ultan, Settleman, Jeffrey, Kobayashi, Susumu, Mark, Eugene J., Rodig, Scott J., Chirieac, Lucian R., Kwak, Eunice L., Lynch, Thomas J., Iafrate, A. John
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2744268/
https://ncbi.nlm.nih.gov/pubmed/19667264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.22.6993
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares